Australia's most trusted source of pharma news
Saturday, 08 May 2021
News Headlines
SEARCH NOW
Special Report
November 2020 PBAC outcomes
Posted 21 December 2020
The PBAC has recommended just over half of the submissions submitted to its July meeting, although only six major new listing requests out of 15 were included in the recommendations.
It handed out a total of 25 recommendations, of which 15 were major submissions and 10 were minor submissions.
Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here
Posted 21 December 2020
The PBAC has recommended just over half of the submissions submitted to its July meeting, although only six major new listing requests out of 15 were included in the recommendations.
It handed out a total of 25 recommendations, of which 15 were major submissions and 10 were minor submissions.
Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here
Top of the Hill
Pharma face-slapped for success
Reputation is finding itself under threat again
Reputation is finding itself under threat again
Approvals Action
Low dose Symdeko ticked
Along with one generic drug
Along with one generic drug
Special Report
March 2021 PBAC outcomes
Less than a quarter of major new listing requests recommended
Less than a quarter of major new listing requests recommended